Oceania Natural Ltd — Preliminary results and delisting proposal

Oceania Natural Ltd — Preliminary results and delisting proposal

Oceania Natural (ONL) is an early-stage New Zealand company involved in producing and distributing food and drink products. ONL has been developing routes to market for key products, particularly water. As part of a capital plan, the company now intends to delist its shares from the NXT market following a shareholder meeting to be held in late June. Investors should be aware that if the delisting proceeds as planned, which is likely, they will shortly not have a ready market for their shares and that new investment is likely to be significantly dilutive.

Analyst avatar placeholder

Written by

Oceania Natural

Preliminary results and delisting proposal

NXT Company Spotlight

04 June 2018

Consumer goods

Price

NZ$1.42

Market cap

NZ$37m

Share price performance

Share details

Code

ONL

Listing

NXT

Shares in issue

26.2m

Business description

Oceania Natural is a producer, distributor and reseller of natural food and drink products sourced from New Zealand and the Pacific Islands, sold both domestically and into China; it is also exploring other markets.

Bull

Tapping into demand for clean NZ products.

Board has strong experience in consumer products companies.

Market potential in new markets.

Bear

Potential dilution on delisting.

High valuation relative to peer group.

Low share liquidity.

Analysts

Paul Hickman

+44 (0)20 3681 2501

Sara Welford

+44 (0)20 3077 5000

Oceania Natural (ONL) is an early-stage New Zealand company involved in producing and distributing food and drink products. ONL has been developing routes to market for key products, particularly water. As part of a capital plan, the company now intends to delist its shares from the NXT market following a shareholder meeting to be held in late June. Investors should be aware that if the delisting proceeds as planned, which is likely, they will shortly not have a ready market for their shares and that new investment is likely to be significantly dilutive.

Preliminary results at March 2018: Increased loss

In the year to March 2018, ONL made a net loss of NZ$2.53m against NZ$0.94m in FY17: the increased loss was largely driven by additional costs on initiatives to develop new markets.Net debt was NZ$2.77m (March 2017: NZ$0.45m). The results are unaudited and are subject to change.

Water acquisition: Adjustments may be material

While ONL is finalising the purchase price for the December 2017 acquisition, we highlight its comment that any gain or loss relating to carrying values of assets acquired may have a material effect on the FY18 results. The company has also now announced that it is seeking additional investment in the plant and that, pending such investment, the plant is not performing to its potential.

Proposed delisting: Short timeframe

Management has started a process to delist from the NXT exchange that is intended to be finalised following a shareholder meeting in late June. Reasons for the decision include: the company’s existing financial position requiring a capital injection; the water plant requiring an (unspecified) investment to bring it to its potential production; and ongoing costs of listing are disproportionate to the company’s scale and represent a disincentive to new investors.

Valuation: Indications are negative

ONL’s FY18 EV/sales multiple is 26.8x, more than 10 times the peer average. Hence, if valued on the same basis as peers, the share value would be much lower. We highlight management’s advice that any agreed pricing for new capital will likely be substantially lower than $1.42 per share. We stress that following delisting, an open market for the shares will not exist and it is likely to be very difficult for investors to trade their shares. In addition, new investment is likely to have a significant dilutive effect on existing shareholders.

Historical performance

Year
end

Revenue
(NZ$000s)

EBITDA

(NZ$000s)

EBIT

(NZ$000s)

NPAT

(NZ$000s)

Net cash

(NZ$000s)

Net assets

(NZ$000s)

03/15

1,512

45

20

1

4

(65)

03/16

3,351

305

276

183

(736)

1,874

03/17

2,429

(865)

(911)

(936)

(453)

5,260

03/18

1,483

(2,151)

(2,205)

(2,529)

(2,771)

3,751

Source: ONL

Oceania Natural coverage is provided through the NXT Research Scheme

Preliminary results at March 2018

In the year to March 2018, ONL made a net loss of NZ$2.53m against NZ$1.04 in the prior year:

Exhibit 1: Oceania Natural FY18 vs FY17

Year to March (NZ$m)

FY18

FY17

Revenue

1.48

2.43

Cost of sales

(0.73)

(1.79)

Gross profit

0.75

0.64

Gross profit margin (%)

50.7%

26.2%

EBITDA

(2.15)

(0.87)

EBIT

(2.21)

(0.91)

PBT

(2.53)

(1.04)

NPAT

(2.53)

(0.94)

EPS (c)

(7.28)

(3.85)

Weighted shares in issue (m)

26.2

26.1

Source: ONL

The company has already commented on its strategic journey to become a food and beverage company with values of quality products and ethical sourcing, with a focus on water and Noni juice. While this transition from its original identity as a trader in Manuka honey remains in progress, revenue has fallen back, at only c 60% the level of FY17. Although gross profit at NZ$0.75 was actually marginally higher than in FY17 on a different product mix, operating expenses and overheads were significantly higher than in FY17 as a result of initiatives to develop its new markets. It was these cost increases that primarily drove the NZ$1.5m increase in the net loss for the year.

Trading in China: Improved market information

In FY18, ONL’s China-based subsidiary, Oceania Natural Wuxi, continued to sell into new sales channels and to new distribution partners. As a result, management believes it has improved its understanding of the relative demand for different products, as well as the geographical split of demand, which should enable it to target sales more appropriately in the coming year. In addition, there should be opportunities for additional product sales around traditional festivals such as Christmas, Gregorian New Year, Chinese New Year and Valentine’s Day.

Trading in additional geographies: Key future markets

In FY18, ONL’s Noni juice was shipped to Japan, Korea and Singapore. Management reports that these markets are growing, while still remaining small, but regards these regions as key markets for the future.

Net debt

At March 2018, the company had net debt of NZ$2.77m, compared with NZ$0.45m at March 2017.

ONL’s water business acquisition in December 2017

In December 2017, ONL acquired from Aquity International and its subsidiary company, Kauri Springs Aqua, business assets comprising their water bottling, sales and distribution operation located at Kaiwaka, which trades in New Zealand under the ‘Water for Everyone’ brand. The purchase consideration was a maximum $740,000 plus stock, subject to downward-only adjustment based on performance in the period to March 2019.


The company stated that the acquisition would allow ONL to:

further enhance and optimally exploit the bottling operations;

ensure the quality of the water products produced from the Kaiwaka facility;

receive an uninterrupted supply of water products for both local and export markets;

leverage off existing distribution channels and generate sales revenue for ONL; and

work with its existing suppliers of products being exported, as this acquisition supports diversification of the supplier base and mitigates reliance on specific manufacturers to meet future ONL production requirements.

ONL is currently finalising the purchase price and has commented that any gain or loss resulting from the increase or decrease in the carrying values of the assets acquired may have a material effect on these results, which has not yet been included in these preliminary results. The assets purchased have been shown at original cost on settlement and have not been revalued in these results. The company has also now announced that it is seeking additional capital to invest in the Kaiwaka plant.

Results against key operating milestones (KOMs)

ONL reset its KOM targets in January 2018 to reflect the changing composition and structure of its business. Results for FY18 indicate that ONL overachieved its overall sales target by 10%, based on New Zealand sales that were 23% higher than the KOM target, even though the smaller overseas sales category were 22% lower than the KOM target.

Exhibit 2: Actual results and key operating milestones

NZ$000s

FY18 actual

FY18 KOM target

Total sales

1,483

1,350

New Zealand sales

1,164

941

Overseas sales

319

409

Water sales as a % of total revenue

*

55%

Total litres of water packed (000s)

*

1250

Source: ONL. Note: *not reported: see below.

ONL has not reported against its two new KOMs for water sales as a percentage of total revenue, and the total litres of water packed. Management has stated elsewhere that, as a result of the need for further investment in the water plant, revenue and profits have not yet reached expectations.

KOM waiver

ONL has been granted a waiver of its obligation under NXT market regulations to set new annual KOM targets. The company does not consider that it has sufficient certainty to set targets, given that it is currently seeking new capital. It will also be clear to investors that in the likely event delisting goes ahead, ONL will no longer be subject to NXT market rules.

Proposed delisting: Short timeframe

The company has initiated a process to cancel its NXT market listing and to continue as a private New Zealand company. The intended process will be a special shareholder meeting in late June where a vote will be held on cancellation. Subject to the vote being carried, the listing will be cancelled shortly thereafter. Given the voting majority of board members, the proposals are likely to be carried, in our view.

Reasons for delisting proposal: Trading, financial, investment

We summarise management’s reasons behind the delisting proposal as follows:

Trading: Decline of original market and diversification to water market

When ONL listed in 2016, its main business was the sale of manuka honey, mainly into the Chinese market. The company intended to build on this profitable base to diversify into other retail products and to build a distribution network in China. In fact, pricing for manuka honey dropped sharply in China amid a scenario of aggressive discounting. While the market has recovered somewhat, margins are still significantly less than they were two years ago.

As a result, ONL decided to accelerate product diversification by moving into water products, leading to the purchase in 2017 of the Kauri Springs water plant. That purchase was partly debt financed with NZ$1.15m of this loan falling due August 2018, which will need to be refinanced (the existing lender has reportedly verbally indicated willingness to renew the loan). In addition, the water plant requires investment to improve its efficiency and lower costs, before it can deliver expected levels of profitability. Management does not quantify the scale of investment required.

Financial position: Net debt and upcoming obligations

At March 2018, the company had net debt of NZ$2.77m, made up of loans and borrowings totalling NZ$2.95m and cash of NZ$0.18m.

Management sets out its upcoming financial obligations as follows:

NZ$86,000 of Manuka Bonds due for repayment in mid-June. ONL believes it has resources in place to cover this repayment.

A NZ$400,000 related party loan due for repayment at end-June. The lender has confirmed its willingness to extend this loan.

As noted above, the NZ$1.15m loan over the plant is expected to be extended in August.

A further $43,000 of Manuka Bonds are due for repayment in August, although ONL believes it will be able to cover this out of available funds.

Capital plan: Priority for new investment

ONL is in discussions with potential investors for capital investment in ONL. The company advises that no terms or pricing have been agreed, but we would highlight management’s advice that any agreed pricing will likely be substantially lower than the recent market price of $1.42 per share.

Considerations behind the plan are as follows:

It was not considered tenable for ONL to remain listed. To do so would have entailed restructuring operations to focus on water and remove other product lines; however, this would have removed existing revenue, which would not be replaced until investment in the water plant had generated a return, which would take time.

Management believes that compliance costs of listing at c NZ$0.65m pa are now disproportionate to the scale of ONL’s revenues (NZ$1.48m for FY18). Management states also that while ONL has limited liquidity in its shares, it does not believe the benefits of being listed are being realised for shareholders.

The delisting is intended to give comfort to prospective investors that capital they may introduce to ONL will be invested in the business for revenue growth and not spent on compliance costs.

Valuation: Peer comparison and current developments

We consider the share price in relation both to industry peers, and in the light of current developments.

Peer comparison

As in the past, we compare ONL’s share price with listed peers. These are predominantly Australian and New Zealand honey and health products companies. All are well-established companies in more mature stages of their lifecycles. As a consequence, the average EV/sales multiple of this group of 2.3x (Exhibit 3) is well below the EV/sales multiple implied by ONL’s current market capitalisation.

Exhibit 3: Peer comparison based on 12-month forward consensus

Company

Country

Currency

Price

Market cap
(m)

P/E
(x)

EV/sales
(x)

EV/EBITDA
(x)

EBITDA

margin (%)

Operating margin (%)

Blackmores

Australia

A$

152

2,626

36.4

3.8

23.8

15.8

14.2

Capilano Honey

Australia

A$

17

157

16.7

1.2

10.5

11.5

9.8

Comvita

New Zealand

NZ$

5.9

267

28.1

1.8

16.7

10.9

7.9

Average

 

 

27.1

2.3

17.0

12.7

10.7

Source: Bloomberg. Note: Prices as at 31 May 2018.

With a market capitalisation of NZ$37m and net debt of NZ$2.8m at 31 March 2018, the EV/sales multiple on ONL’s actual sales for FY18 is 26.8x, which is more than 10 times as much as the peer average. We suggest that this high multiple reflects the fact that, while the company is in the process of developing new markets, its current sales do not reflect the value implied by the current share price in the same way as more established peers. Conversely, if the shares were valued in line with existing sales and on the same basis as peers, their value would be much lower.

Current developments

We note that the company has stated its intention to delist from the NXT market in the near future. In addition, as stated above, it is relevant that management is indicating that the any pricing agreed with new investors will likely be substantially lower than the current market price of $1.42 per share. Management explains that it wishes to make any investment in ONL compelling to new investors. As a result, we would suggest that:

Following delisting, an open market for the shares will not exist and it is likely to be very difficult for investors to trade their shares.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

295 Madison Avenue, 18th Floor

10017, New York

US

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority. Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
This report has been commissioned by NZX Limited (“NZX”) and prepared and issued by Edison Investment Research (NZ) Limited (“Edison”). This report has been prepared independently of NZX and does not represent the opinions of NZX. NZX makes no representation in relation to acquiring, disposing of or otherwise dealing in the securities referred to in this report.

All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however neither NZX nor Edison guarantees the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in this report may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Investment Research Pty Ltd (Corporate Authorised Representative (1252501) of Myonlineadvisers Pty Ltd (AFSL: 427484)) and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. This research is distributed in the United States by Edison US to major US institutional investors only. Edison US is not registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison US does not offer or provide personalised advice. This research is distributed in New Zealand by Edison). Edison is the New Zealand subsidiary of Edison Investment Research Limited. Edison is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. The distribution of this document in New Zealand is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the New Zealand Financial Advisers Act 2008 (FAA) (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. Edison publishes information about companies in which we believe our readers may be interested, for informational purposes only, and this information reflects our sincere opinions. This report is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, this report should not be construed as a solicitation or inducement to buy, sell, subscribe, or underwrite any securities referred to in this report. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. Edison has a restrictive policy relating to personal dealing. Edison does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, estimates of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. To the maximum extent permitted by law, NZX, Edison, either of their affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication.

NeuroVive Pharmaceutical — KL1333 Ph I positive; rights issue oversubscribed

On 27 April 2018, NeuroVive announced that the planned rights issue was oversubscribed (104%), delivering SEK78.5m in gross proceeds and funding the operations into 2019. The fundraise allows NeuroVive to focus on the initiation of the NeuroSTAT (traumatic brain injury) Phase IIb trial (H218/H119) and the Phase Ib KL1333 (genetic mitochondrial diseases) trial in Europe (H218). The latter project was bolstered by the recent news from the South Korean partner, Yungjin Pharm, which reported a positive outcome in its own locally run Phase I trial with KL1333. Our updated valuation is SEK1.62bn or SEK17.7/share (SEK18.0/share previously).

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free